当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析

回盛生物

(300871)

  

流通市值:44.45亿  总市值:44.45亿
流通股本:2.02亿   总股本:2.02亿

回盛生物(300871)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.88亿元,每股收益1.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益211807.36万元,未分配利润42353.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产295801.18万元,负债83993.81万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,259,534,029.86822,199,978.17399,068,578.251,200,327,933.81
营业总成本1,066,684,555.95709,473,026.97358,778,707.571,229,801,069.41
其他经营收益
营业利润216,564,082.86135,762,243.5250,869,008.58-29,085,123.15
利润总额214,587,790.71133,574,563.2250,681,198.76-28,973,419.48
净利润188,484,725.84117,545,832.9544,777,497.12-19,773,164.88
每股收益
其他综合收益-2,310,824.87-1,167,402.03--
综合收益总额186,173,900.97116,378,430.9244,777,497.12-19,773,164.88
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,270,333,809.171,267,644,719.021,346,009,223.511,312,585,417.22
非流动资产:
非流动资产合计1,687,677,951.271,700,352,693.751,700,140,552.571,702,097,447.8
资产总计2,958,011,760.442,967,997,412.773,046,149,776.083,014,682,865.02
流动负债:
流动负债合计745,165,592.68808,317,682.1948,094,016.86923,315,102.83
非流动负债:
非流动负债合计94,772,523.9294,231,379.73513,027,212.71626,164,645.33
负债合计839,938,116.6902,549,061.831,461,121,229.571,549,479,748.16
所有者权益(或股东权益):
归属于母公司股东权益合计2,108,392,513.212,058,589,798.431,578,253,746.331,457,576,824.02
股东权益合计2,118,073,643.842,065,448,350.941,585,028,546.511,465,203,116.86
负债和股东权益合计2,958,011,760.442,967,997,412.773,046,149,776.083,014,682,865.02
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计991,584,938.53665,343,519.3332,255,252.141,027,042,785.78
经营活动现金流出小计810,069,877.78541,490,793.71274,294,987.98983,510,938.97
经营活动产生的现金流量净额181,515,060.75123,852,725.5957,960,264.1643,531,846.81
投资活动产生的现金流量:
投资活动现金流入小计494,695,272.97277,952,252.1396,164,407.02668,897,903.94
投资活动现金流出小计639,792,156.12397,172,454.43223,629,940.01770,712,692.07
投资活动产生的现金流量净额-145,096,883.15-119,220,202.3-127,465,532.99-101,814,788.13
筹资活动产生的现金流量:
筹资活动现金流入小计227,358,689.85203,658,178124,116,220556,087,472
筹资活动现金流出小计295,411,357.08240,394,561.2787,759,468.86542,111,104.34
筹资活动产生的现金流量净额-68,052,667.23-36,736,383.2736,356,751.1413,976,367.66
汇率变动对现金及现金等价物的影响-130,204.92108,497.32404,235.28-613,772.49
现金及现金等价物净增加额-31,764,694.55-31,995,362.66-32,744,282.41-44,920,346.15
期末现金及现金等价物余额152,827,248.69152,596,580.58151,847,660.83184,591,943.24
补充资料:
现金及现金等价物的净增加额--31,995,362.66--44,920,346.15
TOP↑